Dr. Adam Mead - CML - Chronic myeloid leukemia
PROFESSOR OF HAEMATOLOGY
University of Oxford
Consultant Physician
MRC Senior Clinical Fellow
""My research is focused on understanding how the normal haematopoietic stem/progenitor hierarchy is disrupted during the development of myeloid malignancies. The overarching aim of my research group is to improve the management of myeloproliferative neoplasms (MPN), chronic myeloid leukaemia (CML) and related conditions through better characterisation and therapeutic targeting of malignant stem and progenitor cell populations. My research is closely linked with my clinical practice based at Oxford University Hospitals NHS Trust where I am clinical lead for MPN and CML.""
Extract of Radcliffe Department of Medicine
VIDEOS
Discontinuing treatment and predicting relapse in CML
June 21, 2018, VJHemOnc – Video Journal of Hematological Oncology
Revealing Hidden Mutations -- Cancer, with Dr. Adam Mead
April 7, 2014, fluidigm
Discontinuing treatment and predicting relapse in CML
June 21, 2018, VJHemOnc – Video Journal of Hematological Oncology
Revealing Hidden Mutations -- Cancer, with Dr. Adam Mead
April 7, 2014, fluidigm